475838 | Mifepristone - CAS 84371-65-3 - Calbiochem

475838
Price could not be retrieved
Minimum Quantity needs to be mulitiple of
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited AvailabilityLimited Availability
Stocked 
Discontinued
Limited Quantities Available
Available
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      View Pricing & Availability
      Click To Print This Page

      Overview

      Replacement Information

      Key Specifications Table

      Empirical FormulaCAS #
      C₂₉H₃₅NO₂ 84371-65-3

      Pricing & Availability

      Catalog NumberAvailability Packaging Qty/Pack Price Quantity
      475838-50MG
      Retrieving availability...
      Limited AvailabilityLimited Availability
      Stocked 
      Discontinued
      Limited Quantities Available
      Available
        Remaining : Will advise
          Remaining : Will advise
          Will advise
          Contact Customer Service

          Plastic ampoule 50 mg
          Retrieving price...
          Price could not be retrieved
          Minimum Quantity needs to be mulitiple of
          Upon Order Completion More Information
          You Saved ()
           
          Request Pricing
          Description
          OverviewA cell-permeable synthetic steroid that acts as a potent antagonist of progesterone and glucocorticoid receptors. Inhibits P-glycoprotein (P-gp) function and down-modulates P-gp mediated drug resistance. Displays anti-angiogenic effects and suppresses vascular endothelial growth factor (VEGF) production. Regulates the expression of Fas and FasL in mouse endometrium and TRAIL in prostate cancer cells. As an antioxidant, it offers neuroprotection against controlled cortical impact (CCI) in CA1 pyramidal cells, as well as Aβ-, H2O2-, and glutamate-induced injury to mouse hippocampal HT22 cells.
          Catalogue Number475838
          Brand Family Calbiochem®
          Synonyms(11β,17β)-11-(4-(Dimethylamino)phenyl)-17-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one, RU-486
          References
          ReferencesMcCullers, D.L., et al. 2002. Neuroscience 109, 219.
          Sidell, N., et al. 2002. Ann. N. Y. Acad. Sci. 955, 159.
          Gao, F., et al. 2001. Acta Pharmacol. Sin. 22, 524.
          Hyder, S.M., et al. 2001. Int. J. Cancer 92, 469.
          Lam, F.C., et al. 2001. J. Neurochem. 76, 1121.
          Sridhar, S., et al. 2001. Cancer Res. 61, 7179.
          Behl, C., et al. 1997. Eur. J. Neurosci. 9, 912.
          Greb, R.R., et al. 1997. Hum. Reprod. 12, 1280.
          Gruol, D.J., et al. 1994. Cancer Res. 54, 3088.
          Product Information
          CAS number84371-65-3
          ATP CompetitiveN
          FormYellow solid
          Hill FormulaC₂₉H₃₅NO₂
          Chemical formulaC₂₉H₃₅NO₂
          ReversibleN
          Structure formula ImageStructure formula Image
          Applications
          Biological Information
          Primary TargetProgesterone and glucocorticoid receptors
          Purity≥99% by titration
          Physicochemical Information
          Cell permeableY
          ContaminantsSteroid substances: ≤0.1%
          Dimensions
          Materials Information
          Toxicological Information
          Safety Information according to GHS
          RTECSKG2955000
          Safety Information
          R PhraseR: 60-61

          May impair fertility.
          May cause harm to the unborn child.
          S PhraseS: 22-36/37/39-45

          Do not breathe dust.
          Wear suitable protective clothing, gloves and eye/face protection.
          In case of accident or if you feel unwell, seek medical advice immediately (show the label where possible).
          Product Usage Statements
          Storage and Shipping Information
          Ship Code Ambient Temperature Only
          Toxicity Carcinogenic / Teratogenic
          Storage +2°C to +8°C
          Protect from Light Protect from light
          Do not freeze Ok to freeze
          Special InstructionsFollowing reconstitution aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
          Packaging Information
          Packaged under inert gas Packaged under inert gas
          Transport Information
          Supplemental Information
          Specifications

          Documentation

          SDS

          Title

          Safety Data Sheet (SDS) 

          Certificates of Analysis

          TitleLot Number
          475838

          References

          Reference overview
          McCullers, D.L., et al. 2002. Neuroscience 109, 219.
          Sidell, N., et al. 2002. Ann. N. Y. Acad. Sci. 955, 159.
          Gao, F., et al. 2001. Acta Pharmacol. Sin. 22, 524.
          Hyder, S.M., et al. 2001. Int. J. Cancer 92, 469.
          Lam, F.C., et al. 2001. J. Neurochem. 76, 1121.
          Sridhar, S., et al. 2001. Cancer Res. 61, 7179.
          Behl, C., et al. 1997. Eur. J. Neurosci. 9, 912.
          Greb, R.R., et al. 1997. Hum. Reprod. 12, 1280.
          Gruol, D.J., et al. 1994. Cancer Res. 54, 3088.

          Brochure

          Title
          Alzheimer's Disease Brochure & Technical Guide
          Data Sheet

          Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

          Revision28-April-2009 RFH
          Synonyms(11β,17β)-11-(4-(Dimethylamino)phenyl)-17-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one, RU-486
          DescriptionA cell-permeable, synthetic steroid that acts as a potent antagonist of progesterone and glucocorticoid receptors. Reported to inhibit P-glycoprotein (P-gp) function and down-modulate P-gp mediated drug resistance. Also displays anti-angiogenic effects and suppresses vascular endothelial growth factor (VEGF) production. Shown to regulate the expression of Fas and FasL in mouse endometrium and of TRAIL in prostate cancer cells. As an antioxidant, it is reported to offer neuroprotection against controlled cortical impact (CCI) in CA1 pyramidal cells, as well as Aβ-, H2O2-, and glutamate-induced injury to mouse hippocampal HT22 cells.
          FormYellow solid
          Intert gas (Yes/No) Packaged under inert gas
          CAS number84371-65-3
          RTECSKG2955000
          Chemical formulaC₂₉H₃₅NO₂
          Structure formulaStructure formula
          Purity≥99% by titration
          ContaminantsSteroid substances: ≤0.1%
          SolubilityEthanol (10 mg/ml)
          Storage +2°C to +8°C
          Protect from light
          Do Not Freeze Ok to freeze
          Special InstructionsFollowing reconstitution aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
          Toxicity Carcinogenic / Teratogenic
          Merck USA index14, 6186
          ReferencesMcCullers, D.L., et al. 2002. Neuroscience 109, 219.
          Sidell, N., et al. 2002. Ann. N. Y. Acad. Sci. 955, 159.
          Gao, F., et al. 2001. Acta Pharmacol. Sin. 22, 524.
          Hyder, S.M., et al. 2001. Int. J. Cancer 92, 469.
          Lam, F.C., et al. 2001. J. Neurochem. 76, 1121.
          Sridhar, S., et al. 2001. Cancer Res. 61, 7179.
          Behl, C., et al. 1997. Eur. J. Neurosci. 9, 912.
          Greb, R.R., et al. 1997. Hum. Reprod. 12, 1280.
          Gruol, D.J., et al. 1994. Cancer Res. 54, 3088.